Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 01 Jun 2023 for Xenon Pharmaceuticals Inc., €648k. Read the official filing
Filing timeline
BuySaleSimon N. Pimstone
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Simon N. Pimstone: trading record in brief
Simon N. Pimstone, listed as chief executive, appears in our data through filings on Xenon Pharmaceuticals Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 24 May 2021 to 30 May 2023.
Sales make up the whole of the open-market record (4 sales, €2.8M). Other entries cover 3 option exercises. In 2023 alone, the filings show no purchases and 1 sale.
The newest entry dates from 1 June 2023: an open-market sale of €648k, in Xenon Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Simon N. Pimstone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
18,006 shares@ US$38.6327.7% of flowCommon SharesSEC:0000950170-23-025802:0
41,152 shares@ US$2.684.4% of flowCommon SharesSEC:0001209191-23-017636:0
43,135 shares@ US$37.9167.8% of flowCommon SharesSEC:0001209191-22-046015:0
2,500 shares@ US$30.8010.8% of flowCommon SharesSEC:0001209191-22-017418:0
10,288 shares@ US$3.675.2% of flowCommon SharesSEC:0001209191-22-017341:0
17,557 shares@ US$31.3373.4% of flowCommon SharesSEC:0001209191-21-064931:0
22,633 shares@ US$3.7610.6% of flowCommon SharesSEC:0001209191-21-035911:0
7 of 7 declarations
